Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 16, 2009
A rapid PSA half-life following docetaxel chemotherapy is associated with improved survival in hormone refractory prostate cancerMikael Hanninen, Peter Venner, Scott North
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 20, 2014
Improving the outcome of patients with muscle invasive urothelial carcinoma of the bladder with neoadjuvant gemcitabine/cisplatin chemotherapy: A single institution experienceFaraj El-Gehani, Scott North, Sunita Ghosh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 13, 2009
A case of indirect cauda equina syndrome from metastatic prostate cancerShilo Lefresne, Alysa Fairchild, Aalo Bistritz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Associations between exercise and quality of life in bladder cancer survivors: a population-based studyKristina H Karvinen, Kerry S Courneya, Scott North, et al.
Journal of Cancer Survivorship : Research and Practice|July 24, 2008
Exercise programming and counseling preferences in bladder cancer survivors: a population-based studyKristina H Karvinen, Kerry S Courneya, Peter Venner, et al.
The Journal of Urology|October 24, 2002
The lack of long-term effect of Cisplatin based combination chemotherapy on serum cholesterol for treatment of testicular cancerDavid W Fenton, Sunil Verma, Peter Venner, et al.
The Canadian Journal of Urology|December 21, 2019
Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer settingJordan Hill, Mike Paulden, Christopher McCabe, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 11, 2017
High fat mass associates with occurrence of targeted therapy-induced left ventricular ejection fraction reduction in patients with renal cell carcinomaSeyyed Mohammad Reza Kazemi-Bajestani, Harald Becher, Peter Venner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled studySami Antoun, Laura Birdsell, Michael B Sawyer, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 14, 2011
Furthering the prostate cancer screening debate (prostate cancer specific mortality and associated risks)G Michael Allan, Michael P Chetner, Bryan J Donnelly, et al.
Pageof 3